LexaGene Provides a Corporate Update
05 oct. 2020 09h02 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene’s CEO Provides Video Message on Company’s Progress and Announces Appointment of Dr. Shelley Rankin to Company’s Scientific Advisory Board
21 sept. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Engages Tailwinds Research Group
18 sept. 2020 17h00 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 18, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Holdings Announces Closing of CAD$13.29 Million Financing
09 sept. 2020 09h43 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) ("LexaGene" or the "Company") is pleased to announce that it has closed its previously...
LexaGene Engages Contract Manufacturer to Support Product Launch
17 août 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Hires First Direct Sales Executives and announces exercise of warrants
14 juil. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 14, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops genetic analyzers for rapid...
LexaGene Introduces its Commercial Product MiQLab™
13 juil. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops genetic analyzers for rapid...
LexaGene to Host Webcast on July 14, 2020
08 juil. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 08, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops genetic analyzers for rapid...
LexaGene to Present at Lytham Partners Virtual Investor Growth Conference
22 juin 2020 08h49 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Provides Status Update on COVID-19 Testing at a Major Hospital Laboratory
18 juin 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...